Introduction
Genetically engineered resistance has been reported for numerous plant RNA viruses on the basis of the transformation of plants with a pathogen-derived gene (for review, see Wilson, 1993) . These studies involved sequences generated from the viral coat protein gene (Powell-Abel et al., 1986 ; for review, see Beachy et al., 1990) , the viral movement gene (Cooper et al., 1995) , and the viral replicase genes (Golemboski et al., 1990; for review, see Carr and Zaitlin, 1993) . In all cases, the concept of pathogenderived resistance has been proven successful as a strategy to generate plants resistant against systemic infection by the corresponding virus. We have studied replicasemediated resistance against cucumber mosaic virus (CMV).
CMV is a positive-sense RNA virus, with numerous strains exhibiting the largest host range of any plant virus. The CMV genome contains five genes encoded by three genomic RNAs (for review, see Palukaitis et al., 1992) . The replicase proteins 1 a (111 kDa) and 2a (97 kDa) are encoded by RNA1 and RNA2, respectively. An additional protein of unknown function, 2b (11.3 kDa), is encoded by CMV RNA2 from a small open reading frame overlapping the C-terminus of the 2a protein, but is expressed only from a subgenomic RNA designated RNA4A (Ding et al., 1994 (Ding et al., , 1995 . RNA3 encodes two proteins. The 3a (30 kDa) protein, involved in viral movement (Kaplan et al., 1995) , is encoded by the 5' proximal open reading frame of RNA3, whereas the coat protein open reading frame is located in the 3'-proximal half of RNA3, and the 24.5 kDa coat protein is translated from a subgenomic RNA designated RNA4. Strains of CMV can be divided into two major subgroups, I and II, on the basis of their sequence similarity. The two subgroups generally show about 75% sequence similarity to each other, while strains in the same subgroup show 97%-99% sequence identity. In addition, strains of subgroup I do not appear to encapsidate the subgenomic RNA4A. Since RNA1 and RNA2 of strains in the two subgroups are interchangeable, the two subgroups are both considered to be the same virus, CMV (Palukaitis et al., 1992) . Full-length cDNA clones of the three genomic RNAs of several strains have been constructed. Infectious RNAs can be transcribed in vitro from these cDNA clones by using bacterial promoters (Hayes and Buck, 1990; Rizzo and Palukaitis, 1990; Suzuki et al., 1991; Boccard and Baulcombe, 1992; Zhang et al., 1994) .
Replicase-mediated resistance against CMV is based on the Agrobacterium-mediated transformation of tobacco (Nicotiana tabacum) plants with a cDNA clone containing a truncated form of CMV RNA2 of the subgroup I strain Fny-CMV (Anderson et al., 1992) resulting in the expression of RNA2 with a 94 nt deletion in the 2a gene (Figure  1 B) . The deletion encompasses the sequences encoding the conserved GDD motif of viral polymerases and causes a frameshift leading to the production of a truncated 2a protein of about 70 kDa in the transgenic plants (Carr et al., 1994) . Such transgenic plants expressed resistance to systemic infection by Fny-CMV (Anderson et al., 1992) . The resistance has been shown to be first of all independent of the type of inoculum (RNA versus virus particles) and the concentration as well as the temperature (Anderson et al., 1992) ; second, effective at the single-cell level (Carr et al., 1994) ; and third, effective against subgroup I strains of CMV, but ineffective against subgroup II strains of CMV (Zaitlin et al., 1994) . It was also shown that three more distantly related subgroup I strains originating from Asia were able to overcome resistance (Zaitlin et al., 1994) . Previously it was shown that the ability of one of these strains, K-CMV, to break resistance mapped to RNA2 (Hellwald and Palukaitis, 1994) . Sequence determination revealed 92.4% sequence similarity between Fny-CMV and K-CMV RNA2. The presence of common restriction sites ( Figure 1A ) allowed us to generate chimeric constructs between both RNA2 cDNA clones. In this study, the interactions of various chimeric constructs with replicase-mediated resistant plants were analyzed to determine both the potential mechanisms of replicase-mediated resistance against CMV and the specific viral targets for the resistance mechanisms. or the pseudorecombinant virus F1K2F3 (RNA1 and RNA3 from the Fnystrain and RNAPfrom the Kstrain). The development of a systemic infection in transformed plants was delayed by about 2 days as compared with the development of infection in nontransformed plants, in about 6-week-old plants at the 3-to 4-leaf stage. On the inoculated leavesof these nontransformed plants, no symptoms were visible with the above viruses, whereas the development of local lesions was observed on transgenic resistant plants of the same age. Once an infection was established, there was no difference in the development of systemic symptoms between the transgenic and the nontransformed plants. Viral replication in the inoculated leaves was studied in more detail to characterize the resistance with regard to its effect on viral replication. To characterize sequence domains potentially involved in breaking resistance at the level of the effects on viral replication, chimeric constructs were generated between RNA2 of the strains Fny-CMV and K-CMV. These constructs, in a mixture with infectious in vitro transcripts of the full-length cDNA clones of Fny-CMV RNA1 and RNAB, were then inoculated to nontransformed plants and to transgenic resistant plants. Evaluation of infection in the inoculated leaves was done initially by visual symptom analysis (Table 1) . For constructs analyzed in more detail later on, viral RNA accumulation was then analyzed in symptom-bearing areas, in inoculated as well as in noninoculated tissue, by Northern blot hybridization. For the sake of brevity, the various pseudorecombinants, all involving RNA1 and RNA3 of Fny-CMV and RNA2 of a chimera, will be referred to by the name of the chimeric RNA2 construct (Table 1) .
Results

Symptom
Three different phenotypes were observed with regard to the severity of symptoms in the inoculated leaves and are characterized by the number of plus symbols in Table  1 . Differences between these three groups were mainly based on the number and the time of appearance of lesions, and the nature of the lesions (necrotic or chlorotic). Constructs with less than 1 kb of sequences derived from K-CMV RNA2 (numbers 6-8,13, and 20-23; Table 1 ) produced only a few very faint lesions in the inoculated leaves (plus in Table 1 ). The lesions were chlorotic and appeared about 5-6 days postinoculation, but were evaluated after 8 days postinoculation in Table 1 . The second type of local response (double plus in Table 1 ) is represented by constructs with at least 1 kb of sequence derived from K-CMV RNA2 (numbers2-5,9,10, 15, 16, and 17; Table  1 ) and 3 days after inoculation with construct pF-X (number 10; Table 1).
in the green tissue outside the lesions to determine whether lesion formation was accompanied by virus localization. These data were then compared with results obtained from experiments done in protoplasts.
As demonstrated in Figure  28 , both constructs pF-X (number 10; Figure 5A shows the kinetics of viral RNA accumulation for pK-NHd and pF-NNr in transgenic protoplasts, and Figure  5B shows the systemic infectivity data for the same viral RNAs. The ability of pK-NHd (number 14; Table  1 ) to replicate to higher levels in single cells ( Figure  5A ) did not lead to the ability to infect transgenic plants systemically ( Figure  5B and Table 1 ). On the other hand, a reduction in replication efficiency ( Figure  5A ) was not sufficient to prevent pF-NNr (number 16; Figure  28 ) and protein (see Figure  4 ) in inoculated leaves of transgenic plants, as well asviral RNA in transgenic protoplasts (see Figure  3 ). In addition, another construct, pF-C, was generated by using the Cfr 101 site common to constructs pF-209 and pK-232 (see Figure  1A ). pF-C, which differs from pF-N (number 11; Table  1 ) by 18 nt, has an amino acid sequence in the encoded 2a gene identical to that of pF-N (see Figure  1 C putative amino acid sequence of the K-CMV 2a protein, but containing 181 Fny-CMV RNA2-like silent nucleotide changes that potentially could prevent it from breaking the resistance, was generated by using site-directed mutagenesis and tested on the transgenic plants. The construct was based on pK-NHd (number 14; Table l), which contains 185 nucleotide changes from pF-209, but cannot infect the transgenic plants systemically (Table I) , even though it encodes a 2a protein with only three amino acid differences from the complete K-CMV 2a protein (see Figure 1C) . The changes in the amino acid sequence were engineered into pK-NHd to create pK-NHd/3mut, which was then tested along with pK-232, the K-CMV full-length cDNA clone, with regard to their abilities to infect the transgenic plants systemically. With the construct pKNHdl3mut (see Figure 1 C ), 6 of 20 plants became infected about 12 days postinoculation, whereas 17 of 20 plants were infected with pK-232 8 days postinoculation.
Although pK-NHd/3mut in some cases did infect the transgenic plants systemically, which indicates only partial resistance against this virus, there is a significant difference with regard to the ability to infect the transgenic plants systemically between the two constructs encoding identical putative amino acid sequences. Both pK-NHd Table 1 ) and pF-C (see Figure 1A ) have identical putative amino acid sequences, but pF-N contains 18 nucleotide differences in a stretch of about 370 nt derived from the K-CMV RNA2 sequence.
Construct pF-X (number 10; Figure lA) , while construct pF-NNr (number 16; Table 1 ) contains only about 1200 nt derived from K-CMV RNA2 (pK-232).
and pK-NHdl3mut showed infectivity profiles identical to that of pK-232 on nontransformed tobacco, indicating that differences in the RNA sequence did not have any detectable effect on the infectivity of the chimera or the mutant.
Similar data were obtained with regard to the mechanism effective at the level of viral replication. In this case, different constructs were compared with regard to their ability to replicate in transgenic protoplasts. In Figure 6A , it is shown that viral RNA accumulation was reduced 20-fold after infection of protoplasts with pF-C (see Figure 1A) as compared with pF-N (number 11, Table l), although there are no amino acid differences between the 2a proteins encoded by these two constructs. Steady-state levels of viral RNA were even more reduced after infection with pF-X(number 10; Table 1 ). Furthermore, theaccumulation pattern of pF-BHc (number 17; Table 1 ) was reduced 12-fold compared with that of pK-232 ( Figure 6B ). Since pFBHc represents a construct with K-CMV sequences present outside of the coding region for the 2a gene (see Figure  1 A), a direct effect of the replication inhibitory mechanism on the viral 2a replicase protein can be ruled out. RNA accumulation was even more reduced after infection with construct pF-NNr (number 16; Table !), again confirming the positive correlation between the amount of K-CMV sequence present in RNA2 and the ability to replicate in protoplasts. Thus, since all the constructs tested showed similar replication kinetics in protoplasts made from nontransformed tobacco, the differences observed in the ability of various constructs to replicate in transgenic protoplasts can only be based on the differences in the nucleotide sequence present in the different constructs, indicating that RNA acts as the target for the mechanism against viral replication.
Discussion
In this report, we analyzed the potential mechanism(s) of replicase-mediated resistance against CMV (Anderson et al., 1992) . It has been demonstrated that replicasemediated resistance against CMV is effective at the singlecell level and therefore directed against viral replication (Carr et al., 1994 ; this report). Our results indicate that in the case of the inhibition of CMV replication, viral RNA serves as the target for the resistance mechanism. Furthermore, we show the existence of an additional, independent mechanism of replicase-mediated resistance against viral movement. Evidence is presented that viral RNA is also the target for this mechanism. In the case of replicase-mediated resistance against alfalfa mosaic virus, a protein-mediated mechanism has been suggested, where the nonfunctional 2a transgene protein would bind the 1 a replicase protein, subsequently inhibiting the formation of a functional replicase complex (Brederode et al., 1995) . The mechanism suggested for the alfalfa mosaic virus system is unlikely to apply to the situation described here for CMV. The participating complex, i.e., the nonfunctional transgene protein and the functional viral replicase la protein, forming a nonfunctional replicase complex, would be the same for infections involving all of the chimeric constructs tested here. Since the various chimeras (Table 1) all contain the same source of RNAl, and they all showed similar kinetics of infection on nontransformed tobacco plants, they should all be affected similarly by the nonfunctional replication complex. Matzke and Matzke (1995) summarized recent data on the phenomenon of (trans-) gene silencing, including a discussion of results from Lindbo et al. (1993) and Smith et al. (1994) on RNA-mediated resistance against two different plant viruses where the transgene is the viral coat protein gene. A so-called sense suppression model has been proposed by these authors in the context of a posttranscriptional gene silencing mechanism based on transgene sequence-specific targeting mediated by small complementary RNA fragments. A similar mechanism, involving an unknown genomic feature, has been proposed for replicase-mediated resistance against potatovirusx by Mueller et al. (1995) . Does the sense suppression model explain the events observed with CMV-resistant plants in this study? The ability of constructs pF-N (number 11; Table 1) and pK-NHd (number 14; Table l), both of which contain 1000 nt of contiguous sequence derived from different regions of Fny-CMV RNA2, to replicate to very high levels in transgenic protoplasts is difficult to rationalize with a mechanism in which sense suppression is simply a function of sequence identity over several hundred nucleotides.
In an alternative model, RNA-RNA recognition has been proposed to be based on the secondary structure of the participating RNAs, with interaction starting either at the stem (Cameron and Jennings, 1991) or the loop (Eguchi and Tomizawa, 1991) of a secondary stem-loop structure. Because the secondary structure of the entire RNA2 has not been determined for any CMV strain, we can only compare the structures for the terminal, nontranslated -regions. Stem-loop structures have been proposed for both of the nontranslated regions of CMV RNA2 (Ahlquist et al., 1981; Rezaian et al., 1985; Rizzo and Palukaitis, 1988; Pogue and Hall, 1992) . Since Fny-CMV and K-CMV RNA2 have almost identical sequences in the stem region of the stem-loop structures of the 5' and 3' nontranslated regions (Hellwald and Palukaitis, 1994) described for CMV (Joshi et al., 1983) , a specific effect against Fny-CMV RNA based on recognition of stem sequences in the termini seems to be unlikely. Does initial base pairing at the loop in such a secondary structure explain specific recognition and inhibition of Fny-CMV as compared with K-CMV? Whereas the stem-loop structure in the 5' noncoding region forms a simple hairpin, a complex secondary structure that includesseveral stem-loops and a pseudoknot structure has been described for the 3' end (Joshi et al., 1983) . If structures such as these in fact serve as targets for the transgene RNA, it is a reasonable assumption that increasing the number of stem-loops in a certain region would increase the susceptibility of this region for intermolecular interactions. This would explain why.the 5' end of Fny-CMV, with potentially fewer stemloop structures, seems to be a less susceptible target than the 3' end of RNA2, as pF-N and pK-232 showed similar viral RNA accumulation in transgenic protoplasts ( Figure   3 ), but viral RNA accumulation of pF-BHc was reduced 1 P-fold as compared with that of pK-232 (Figure 66 ). Since replacing both noncoding regions of Fny-CMV RNA2 with K-CMV sequences (construct pK-BHc; number 23 in Table  1 ) does not lead to maximal replication rates, clearly either additional stem-loop structures have to be present in the coding regions, or RNA-RNA hybrid formation is only one part of a complex inhibition mechanism.
Why would a mechanism such as the one described above not be effective against K-CMV, since similar secondary structures can be assumed to be present for this strain? Eguchi and Tomizawa (1991) clearly demonstrated that the stability of an RNA-RNA hybrid complex greatly depends on absolute sequence identity in the loops of the secondary structure. A decreased susceptibility of K-CMV to inhibition of replication by the Fny-CMV RNA2 transgene could be explained by single nucleotide differences present in the loops of the proposed secondary structures (Hellwald and Palukaitis, 1994) . The latter have been shown to reduce the stability of RNA:RNA hybrid complexes (Eguchi and Tomizawa, 1991) . Moreover, a less stable complex still might cause some interference with replication, explaining why infection of the transgenic plants by K-CMV is delayed by the resistance mechanism as compared with infection of nontransformed plants. It is also unlikely that the subgenomic promoter for RNA4A in the transcript sequesters the viral replicase, since the subgenomic promoter is on the minus-strand RNA, which first would have to be produced from the plus-strand RNAtranscript, and the inhibition of replication in protoplasts does not correlate with chimeras containing the putative RNA4A subgenomic promoter sequences from pF-209 versus those from pK-232.
By using different chimeric constructs, we were able to show that a second independent mechanism against viral movement is effective in CMV transgenic plants. This indicates an involvement of RNA2 in viral movement. The ability to overcome this mechanism could be mapped to the central third of RNA2. Interestingly, Traynor et al. (1991) were able to show that deleting sequences encoding about 125 C-terminal amino acids (from the 882 amino acid 2a protein) from the 2a gene of brome mosaic virus (BMV) did not reduce the efficiency of replication of this virus in barley protoplasts, but did interfere with its ability to move systemically in intact barley plants. This indicates an involvement of BMV RNA2 in viral movement. The corresponding region in CMV RNA2, encoding the 125 C-terminal amino acids of the 857 amino acid 2a protein, does not overlap with the polymerase-like domain identified in this report to be responsible for the ability of K-CMV to overcome the inhibition of movement in the transgenic plants. The mechanism against viral movement seems to involve the central third of the target RNA2, thereby preventing viral movement, but without destroying the target RNA. In fact, accumulation of this RNA can be unaffected, as pK-NHd shows high accumulation levels for all four viral RNAs in transgenic protoplasts ( Figure 5 ; data not shown). The observation that pK-NHdl3mut is able to break resistance in some cases might be due to the fact that the number (181) of nucleotide differences in this con- cDNA clones from Fny-CMV RNAI, RNAP, and RNA3, described by Rizzo and Palukaitis (1990) , and a cDNA clone from K-CMV RNA2 (Hellwald and Palukaitis, 1994) were used to generate infectious in vitro transcripts (Zhang et al., 1994) . Virus purification and RNA extraction were performed as described by Kapjan et al. (1995) , with the exception that final RNA pellets were resuspended in water. Inoculations with virus were performed at a concentration of 100 pglml and a volume of 10 ~1 per leaf in 50 mM sodium phosphate buffer (pH 7.0) containing 1 mM EDTA. Inoculations with viral RNA were done at a concentration of 10 bglml using 10 ~1 per leaf.
Generation of Chimeric cDNA Constructs
All chimeric constructs presented in this work were based on the Fnyand K-CMV cDNA clones derived from RNA2 described earlier (Rizzo and Palukaitis, 1990; Hellwald and Palukaitis, 1994) . Common restriction sites between both clones were used for the generation of chimeric constructs, which were named for the RNA2 source (K-or Fny-) at the 5'end of the transcript followed by the restriction site(s) used to generate the construct.
The abbreviations of sites used in Table 1 are as follows: Hc, Hincll; N, Ndel; X, Xhol; Hd, Hindlll; Nr, Narl; 8, Bbsl; and S, Styl. An additional chimera, pF-C, involving the Cfr 101 site (see Figure lA) , was also constructed.
Agarose gel electrophoresis, fragment purification, ligation, and transformation were performed as described before (Hellwald and Palukaitis, 1994) . Infectious in vitro transcripts generated from the chimeric clones were combined with infectious in vitro transcripts generated from full-length cDNA clones of Fny-CMV RNA1 and RNA3 (Rizzo and Palukaitis, 1990 ) and inoculated to young tobacco plants. The names used for the corresponding chimericvirusesare identical to the names used forthechimericclones listed in Table 1 . After virus purification and extraction of viral RNA, the chimeras were confirmed by RNA sequencing using primers containing sequences common to both strains. The 3'-terminal sequences that could not be confirmed by RNA sequencing because of strong sequence similarities between RNAl, RNA2, and RNA3 at the 3'end were analyzed by an RNase protection assay (Palukaitis et al., 1994) using a K-CMV RNAP-specific ptobe covering the area from a Plel site at the stop codon to the S'end. Kaplan et al. (1995) , except that the purification step using a 10% sucrose cushion was omitted and replaced by three cycles of differential centrifugation at 200 x g for 4 min. The final pellet was resuspended in 0.55 M mannitol containing 20 mM MES-KOH and simple salts (Coutts and Wood, 1977) to a concentration of 5 x lo5 cells/ml. Electroporation was done with 10 &ml viral RNA and 1 ml of protoplast suspension with three 5 ms pulsesof 200 V in a Progenitor 1 electroporation apparatus (Hoefer Scientific Instruments, San Francisco, CA). At various times after electroporation, protoplasts were pelleted and then subjected to RNA extraction and analysis.
Extraction and Analysis of CMV RNAs Northern blot analysis was performed to detect CMV RNA accumulation in leaves and protoplasts.
About 200 mg of leaf tissue or 1 ml of protoplast solution was typically extracted with 200 pl of 50 mM Tris-HCI (pH 8.0) containing IO mM EDTA and 2% SDS. Further handling of the samples, gel electrophoresis, and subsequent blot analysis were performed essentially as described by Kaplan et al. (1995) . A cDNA probe was generated against all four CMV RNAs by use of a 10 nt 3'-terminal primer complementary to the 3' end of all four RNAs and avian myeloblastosis virus reverse transcriptase (United States Biochemical Corporation) at 42%.
Extraction and Analysis of CMV Proteins Sample preparation, SDS gel electrophoresis, and Western blotting as well as the preparation of antisera against the la, 2a, and 3a proteins and the coat protein have been described elsewhere (Gal-On et al., 1994; Kaplan et al., 1995) .
Extraction
and Analysis of CMV Replicase Activity Membrane-bound RNA-dependent RNA polymerase activity was partially purified from tobacco leaves by the procedure described by Quadt and Jaspars (1991) . Approximately 0.5 ml of microsomal fraction was obtained from 5 g of leaf tissue typically extracted.
We used 20 ~1 of microsomal fraction in a total volume of 50 111 for each assay. After incubation for 1 hr at 37%, the RNAs were extracted with phenolchloroform and recovered by ethanol precipitation. The resuspended RNAs were subjected to electrophoresis on a 3.8% polyacrylamide gel by use of a TBE buffer system.
Quantification
of RNA and Protein Analysis A Hewlett Packard ScanJet llcx was used to scan original blots, X-ray films, or prints. Scan Analysis version 2.21 from BIOSOFT was used for the quantitative analysis of the scans.
Site-Directed Mutagenesis Site-directed mutagenesis was performed to introduce changes in three locations in the putative amino acid sequence encoded in the 2a protein of Fny-CMV to those present in K-CMV, by use of a two-step polymerase chain reaction (PCR) procedure described by Higuchi et al. (1988) . Complementary primer pairs covering and flanking the mutation site in combination with primers complementary to the 3' end and identical to the 5' end of CMV RNA2 (Hellwald and Palukaitis, 1994), respectively, gave primary PCR products that were combined in a second PCR using only the terminal primers. Mutation sites and primer sequences are as follows: 1485 (minus strand), 5-GAGGTTAT-ACCCTTCTTATGA3'; 1485 (plus strand), 5'-TCATAAGAAGGGTA-TAACCTC-3'; 1877/79 (minus strand), SI-GTTCCTGGATCATCAAGT-GAAAT-3'; 1677/79 (plus strand), 5'-ATTTCACTTGATGATCCAGG-AAC-3'; 1824 (minus strand), 5'-GCCAAAATAAGTGAATGCATC-GCC3'; 1824 (plus strand), 5'-GGCGATGCATTCACTTATTTTGGC-3'. The PCR reactions were performed in a 50 pl volume with an initial denaturation step of 2 min at 95%, and subsequently 30 cycles of 1 min at 95%, 1 min at 50°C, and 2 min at 72%, followed by a final step of IO min at 72%. Primary PCR products were gel purified with a Geneclean Kit (United States Biochemical Corporation) and then used for the second PCR with the same program. The secondary PCR productswere blunt-end cloned into the Hincll site of thevector pUCI 8, linearized with the same enzyme. After cloning of the PCR fragment containing the mutation back into the full-length cDNA clone, the entire fragment was sequenced to screen for any additional mutations due to PCR.
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